Cantley, Lewis C.,Christofk, Heather R.,Vander Heiden, Matthew G.
申请号:
AU2007281911
公开号:
AU2007281911B2
申请日:
2007.08.06
申请国别(地区):
AU
年份:
2014
代理人:
摘要:
The invention provides pharmaceutical compositions, kits, and methods of treating cancer, diabetes, obesity, autoimmune disease, and benign prostatic hyperplasia using compounds that selectively inhibit pyruvate kinase M2 and an assay measuring chemical modulation of pyruvate kinase activity.